RCT
Live / Registered — Registered (as of 06 Apr 2021)
What this means for you
Registered since 06 Apr 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87287749
- Registration number
- 6315836
- Mark type
- Stylized text
- Filed
- 03 Jan 2017
- Published for opposition
- 28 Nov 2017
- Registered
- 06 Apr 2021
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; pharmaceutical preparations of engineered eythroid cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, none of the foregoing related chemical research, research services in connection with physics and engineering research, or to photovoltaic installations
Owner
- Rubius Therapeutics, Inc., Cambridge, MA, US
- Rubius Therapeutics, Inc., Cambridge, MA, US
- Rubius Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 06 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Mar 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Feb 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Feb 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Feb 2021 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 30 Sept 2020 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 30 Sept 2020 — FINAL REFUSAL E-MAILED
- 30 Sept 2020 — SU - FINAL REFUSAL - WRITTEN
- 11 Sept 2020 — NOTICE OF REINSTATEMENT E-MAILED
- 09 Sept 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Aug 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Aug 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Sept 2020 — REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
- 03 Sept 2020 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND